首页> 外文期刊>Clinical Rheumatology >The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment
【24h】

The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment

机译:β干扰素治疗后多发性硬化女性患者的全身性硬化发展

获取原文
获取原文并翻译 | 示例
       

摘要

We describe a 38-year-old patient with relapsing remitting multiple sclerosis who subsequently develops systemic sclerosis following a course of interferon B-1a injections. This rare association between MS and systemic sclerosis is interesting due to the added factor of beta interferon therapy prior to the onset of the systemic sclerosis. It is also important, as more patients are treated with interferon B-1a for multiple sclerosis, this is a potential association.
机译:我们描述了一名复发复发性多发性硬化症的38岁患者,该患者随后在注射干扰素B-1a的过程中发展为全身性硬化症。 MS和系统性硬化之间这种罕见的联系很有趣,这是由于在系统性硬化开始之前添加了β干扰素治疗。同样重要的是,随着更多患者接受多发性硬化症的干扰素B-1a治疗,这是一种潜在的关联。

著录项

  • 来源
    《Clinical Rheumatology》 |2008年第11期|1467-1468|共2页
  • 作者单位

    Division of Rheumatology Department of Medicine Rheumatology Unit Alfred Hospital Commercial Road Melbourne VIC 3004 Australia;

    Division of Neurology Department of Medicine Royal Alexandra Hospital 10816-124 St. Edmonton Alberta Canada;

    Division of Rheumatology Department of Medicine University of Alberta 562 HMRC University of Alberta T6G-2S2 Edmonton Alberta Canada;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Beta-interferon; Multiple sclerosis; Systemic sclerosis;

    机译:β-干扰素;多发性硬化;全身性硬化;
  • 入库时间 2022-08-18 02:05:33

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号